Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
1999 1
2000 3
2001 1
2002 2
2003 1
2004 1
2005 1
2006 1
2007 2
2009 1
2010 6
2011 7
2012 7
2013 10
2014 13
2015 9
2016 16
2017 5
2018 8
2019 9
2020 10
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 32430444

103 results
Results by year
Filters applied: . Clear all
Page 1
A case of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis with severe cardiac complications.
Kawamura Y, Miura H, Matsumoto Y, Uchida H, Kudo K, Hata T, Ito Y, Kimura H, Yoshikawa T. Kawamura Y, et al. BMC Pediatr. 2016 Oct 28;16(1):172. doi: 10.1186/s12887-016-0718-3. BMC Pediatr. 2016. PMID: 27793118 Free PMC article.
Prognostic factors of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in children: report of the Japan Histiocytosis Study Group.
Kogawa K, Sato H, Asano T, Ohga S, Kudo K, Morimoto A, Ohta S, Wakiguchi H, Kanegane H, Oda M, Ishii E. Kogawa K, et al. Pediatr Blood Cancer. 2014 Jul;61(7):1257-62. doi: 10.1002/pbc.24980. Epub 2014 Feb 17. Pediatr Blood Cancer. 2014. PMID: 24535916 Clinical Trial.
Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in adults and adolescents-a life-threatening disease: analysis of 133 cases from a single center.
Lai W, Wang Y, Wang J, Wu L, Jin Z, Wang Z. Lai W, et al. Hematology. 2018 Dec;23(10):810-816. doi: 10.1080/10245332.2018.1491093. Epub 2018 Jun 29. Hematology. 2018. PMID: 29957156
Dual Threat of Epstein-Barr Virus: an Autopsy Case Report of HIV-Positive Plasmablastic Lymphoma Complicating EBV-Associated Hemophagocytic Lymphohistiocytosis.
Koizumi Y, Imadome KI, Ota Y, Minamiguchi H, Kodama Y, Watanabe D, Mikamo H, Uehira T, Okada S, Shirasaka T. Koizumi Y, et al. J Clin Immunol. 2018 May;38(4):478-483. doi: 10.1007/s10875-018-0500-4. Epub 2018 Apr 23. J Clin Immunol. 2018. PMID: 29687211
PEG-aspargase and DEP regimen combination therapy for refractory Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.
Wang J, Wang Y, Wu L, Zhang J, Lai W, Wang Z. Wang J, et al. J Hematol Oncol. 2016 Sep 9;9(1):84. doi: 10.1186/s13045-016-0317-7. J Hematol Oncol. 2016. PMID: 27613189 Free PMC article. Clinical Trial.
Clinical features and outcomes of patients with hemophagocytic lymphohistiocytosis at onset of systemic autoinflammatory disorder and compare with Epstein-Barr virus (EBV)-related hemophagocytic lymphohistiocytosis.
Zhao Y, Li Z, Zhang L, Lian H, Ma H, Wang D, Zhao X, Zhang Q, Wang T, Zhang R. Zhao Y, et al. Medicine (Baltimore). 2020 Jan;99(1):e18503. doi: 10.1097/MD.0000000000018503. Medicine (Baltimore). 2020. PMID: 31895784 Free PMC article.
[Clinical features and outcome analysis of 83 childhood Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis with HLH-2004 protocol].
Xiao L, Xian Y, Dai BT, Su YC, Xiao JW, Zheng QC, Zhao XD, Yu J. Xiao L, et al. Zhonghua Xue Ye Xue Za Zhi. 2011 Oct;32(10):668-72. Zhonghua Xue Ye Xue Za Zhi. 2011. PMID: 22339824 Chinese.
103 results
Jump to page
Feedback